GLINTA (Linagliptin INN 5 mg) x 30 TABLETS. Generic name: Linagliptin Brand name: Renata. Class: DPP-4 Inhibitor (Dipeptidyl Peptidase-4 Inhibitor). Pack size: 30 Tablets. Form: Tablets. Strength: 5 mg. Amount: ₦9,400 Description: Glinta contains Linagliptin, a DPP-4 inhibitor used to improve blood sugar control in adults with type 2 diabetes. It works by increasing the levels of incretin hormones, which help regulate insulin and decrease glucose production in the liver. Key features: • Effective Glycemic Control: Helps manage blood sugar levels in type 2 diabetes. • DPP-4 Inhibitor: Increases incretin hormone levels to regulate insulin and reduce glucose production. • Convenient Dosage: Once-daily tablet for ease of use. • Monotherapy or Combination Therapy: Can be used alone or with other antidiabetic medications. Side effects: • Common side effects may include nasopharyngitis, hypoglycemia (especially when used with sulfonylureas or insulin), and cough. Caution: • Prescription Only: Use under the guidance of a healthcare professional. • Monitor Blood Sugar Levels: Regular monitoring of blood sugar levels to ensure effectiveness. • Pregnancy and Breastfeeding: Consult your doctor if you are pregnant, planning to become pregnant, or breastfeeding. • Caution in Kidney Impairment: Not recommended for patients with severe renal impairment or end-stage renal disease. • Keep out of sight and reach of children.
